Evidence map›Paper›PMID 33827326›Full record

ArticleDrug delivery2021

A mechanism for improved talc pleurodesis via foam delivery.

T A Lima, R A Coler, G W Laub, S Sexton, L Curtin, K M Laub, N J Alvarez

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

T A LimaDepartment of Chemical and Biological Engineering, Drexel University, Philadelphia, PA, USA.
R A ColerDepartment of Chemical and Biological Engineering, Drexel University, Philadelphia, PA, USA.
G W LaubDepartment of Cardiothoracic Surgery, Drexel University College of Medicine, Philadelphia, PA, USA.
S SextonLaboratory Animal Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
L CurtinLaboratory Animal Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
K M LaubTDL Innovations LLC, Princeton, NJ, USA.
N J AlvarezDepartment of Chemical and Biological Engineering, Drexel University, Philadelphia, PA, USA.
Drexel University · USRoswell Park Comprehensive Cancer Center · US

Funding

An Improved Method of Delivering a Sclerosing Agent for the Treatment of a Malignant Pleural EffusionR43CA210696 · NCI · TDL INNOVATIONS, LLC · PI LAUB, GLENN W · 2017 to 2017
$225k
NCI NIH HHS R43 CA210696
6 · The paper itself

Abstract

Talcum powder is recognized as the leading drug for pleurodesis, a treatment of choice for malignant pleural effusions. Recently, it was shown that hydrogel foam delivery systems significantly enhanced the number of adhesions between the chest wall and the lung in a New Zealand rabbit model due to the sol-gel transition. However, many questions still remain regarding the cause of improved efficacy, such as: (1) Would only hydrogel foams improve the efficacy of talc pleurodesis? (2) Is it possible to achieve the same efficacy of hydrogels using non-hydrogel foams? 3) What are the physicochemical properties that can be correlated to the efficacy of talc pleurodesis? In this study, we use non-hydrogel foam formulations to determine the efficacy of pleurodesis. Foam stability and rheology of the formulations were correlated to adhesion formation. The results clearly suggest a correlation of pleurodesis efficacy to the viscosity and modulus of the foam delivery system.

Indexed as

AnimalsChemistry, PharmaceuticalDrug StabilityHydrogelsPleurodesisRabbitsRheologyTalcHydrogelsTalcDrug deliveryfoammalignant pleural effusionspleurodesisrheology

Identifiers

PMID33827326
PMCPMC8043610
OpenAlexW3152385388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.